NCT01228513View on ClinicalTrials.gov

Efficacy and Safety of Different Concentrations of ZK245186 in Atopic Dermatitis (AD)

PHASE2CompletedINTERVENTIONAL
Enrollment

263

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

July 31, 2011

Study Completion Date

April 30, 2012

Conditions
Atopic Dermatitis
Interventions
DRUG

ZK245186

Daily topical application

DRUG

Placebo (vehicle without active ingredient)

Daily topical application

Trial Locations (16)

10029

New York

48088

Warren

55432

Fridley

60612

Chicago

77598

Webster

77845

College Station

78229

San Antonio

78759

Austin

83704

Boise

92801

Anaheim

96813

Honolulu

97223

Portland

02114-2508

Boston

332-0031

Kawaguchi Saitama

150-0034

Tokyo

162-0053

Tokyo

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY